Literature DB >> 8386170

Calcium: a mediator of the cellular response to chronic Na+/K(+)-ATPase inhibition.

B M Rayson1.   

Abstract

Chronic reduction of Na+/K(+)-ATPase activity has been demonstrated in a number of cell systems to elicit a cellular homeostatic response. Over the course of this response, there is initially a transient stimulation of synthesis of new Na+/K(+)-ATPase molecules, followed by a delayed decrease in its degradation rate, eliciting an effective increase in the number of active pumps in the membrane. The resultant enhancement of pumping capacity promotes the extrusion of accumulated Na+ ions and restores the intracellular electrolyte milieu to preinsult conditions. No cellular mediators of either component of this response have previously been described. We therefore tested the possibility that changes in [Ca2+]i might contribute to the transient stimulation of synthesis observed. Indeed, an effective synthetic response to the inhibition of Na+/K(+)-ATPase by treatment with ouabain required elevated [Ca2+]i levels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386170

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Ouabain is a reversible inhibitor of myogenic fusion.

Authors:  P G Pauw; G J Hermann
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-01       Impact factor: 2.416

2.  Divergent signaling pathways mediate induction of Na,K-ATPase alpha1 and beta1 subunit gene transcription by low potassium.

Authors:  Gang Wang; Kiyoshi Kawakami; Gregory Gick
Journal:  Mol Cell Biochem       Date:  2006-08-15       Impact factor: 3.396

3.  Decreased Na+/K+ ATPase Expression and Depolarized Cell Membrane in Neurons Differentiated from Chorea-Acanthocytosis Patients.

Authors:  Zohreh Hosseinzadeh; Stefan Hauser; Yogesh Singh; Lisann Pelzl; Stefanie Schuster; Yamini Sharma; Philip Höflinger; Nefeli Zacharopoulou; Christos Stournaras; Daniel L Rathbun; Eberhart Zrenner; Ludger Schöls; Florian Lang
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.